Fast Five Quiz: Are You Prepared to Confront Metastatic Breast Cancer?

Winston W. Tan, MD

December 21, 2021

According to the 5th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 5), biological markers (especially HR and HER2) should be reassessed at least once in the metastatic setting if clinically feasible as discordance between primary biomarker profiles of primary and metastatic breast cancer is well documented. Depending on the metastasis site, technical considerations may need to be discussed with the pathologist.

Learn more about breast cancer treatment protocols.

1 2 3 4 5 6

Next Section

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Fast Five Quiz: Are You Prepared to Confront Metastatic Breast Cancer? - Medscape - Dec 21, 2021.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....

Need a Curbside Consult? Share cases and questions with Physicians on Medscape Consult. Share a Case

Fast Five Quiz: Are You Prepared to Confront Metastatic Breast Cancer?

Tables

Authors and Disclosures

Authors and Disclosures

Author

Winston W. Tan, MD

Comments

Email This

Feedback

Confirm

Update